Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Technology
September 29, 2022 05:00 AM

Michigan startup rolls out breast cancer screening tech (with new $30M in tow)

Crain's Detroit Business
Nick Manes
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    SoftVue-main_i.jpg
    Delphinus Medical Technologies
    The SoftVue technology developed by Delphinus Medical Technologies in Novi is intended for the 40 percent of women with dense breast tissue.

    A Novi-based medical device company focused on better detecting breast cancer is moving toward widespread commercialization, having completed a new $30 million venture capital funding round.

    The installation of the SoftVue technology comes amid Delphinus also closing its $30 million Series D funding round earlier this month. Medical Technologies Inc., a spin-out from the Barbara Ann Karmanos Cancer Institute in Detroit, is tapping into its roots and installing its newly commercialized technology called SoftVue — designed for mammography for the roughly 40 percent of women with dense breast tissue — into the cancer hospital on the Detroit Medical Center campus in the city's Midtown neighborhood.

    The installation of the SoftVue technology — which the U.S. Food and Drug Administration approved last October — comes amid the company also closing its $30 million Series D funding round earlier this month. That will serve as the engine to propel the company forward, Delphinus CEO Mark Forchette said, with plans to install its product in other cancer hospitals around the country in the coming months.

    The fundraising "really enables our continuation" following the FDA approval, Forchette told Crain's.

    "So we've been (preparing) for manufacturing, production, and building out the commercial organization to be able to support this," Forchette continued. "And so this (fundraising) was sort of in parallel with our building up the commercialization. But what it gives us is the fuel to be able to now aggressively deliver robust commercial activity."

    Forchette added that it's "rightly so" that the Karmanos Cancer Institute be the first hospital to have Delphinus' technology on-site, noting that the company's two co-founders — Neb Duric and Peter Littrup — both worked at Karmanos where the company's technology was initially conceived.

    Download Modern Healthcare’s app to stay informed when industry news breaks.

    Mark Forchette

    "As a leading cancer center, we are committed to providing our patients with superior diagnostic and screening technology. The development of SoftVue, in partnership with Delphinus Medical Technologies, will further strengthen our fight against breast cancer that accounts for one in three new cancer diagnoses in women each year," Karmanos President Brian Gamble said in a statement.

    "The key to breast cancer survival is early detection and this new screening device will be lifesaving for so many women in our community," Gamble continued. "Our clinical team worked hard for many years to develop this transformational technology, and we are proud to be the first in the world to offer SoftVue to our patients."

    Some 40 percent of women in the U.S. have dense breast tissue, according to data from the company. Those women have a four to six times greater risk of developing breast cancer because typical mammography alone misses about half the cancers in women with dense breasts, as dense tissue and cancer appear white on mammogram images.

    Delphinus' SoftVue machine and technology is used as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue, according to the company's description of the product.

    SoftVue mammogram uses warm water and ultrasound technology to create a 3D image of the whole breast to detect the presence of cancer in its earliest stages — including masses in dense breast tissue often missed by mammography alone — while avoiding radiation exposure and compression, allowing the radiologist to make a more accurate diagnosis

    The company says use of SoftVue leads to "greater accuracy and potentially fewer biopsies than full-field digital mammography (FFDM) alone," and "is completed with no compression or radiation, and its PMA indication for use allows SoftVue exams to be performed at the same appointment as screening mammograms, facilitating a streamlined workflow and rapid delivery of results."

    The Series D funding for the company, which closed earlier this month, included investment from a mix of new and existing investors, including Arboretum Ventures, North Coast Technology Investors and Venture Investors, all with offices in Ann Arbor. Also participating in the round were Beringea of Farmington Hills, Hopen Life Science Ventures out of Grand Rapids and Waycross Ventures in Menlo Park, Calif.

    "Our board of directors and investors are very excited to launch into commercial activities with SoftVue," Paul McCreadie, partner and COO of Arboretum and Delphinus' board chair, said in a statement.

    "The successful completion of a rigorous clinical study that resulted in the PMA approval we received last year for dense breast screening will allow the Delphinus team to leverage the unique technology of SoftVue to change the paradigm for dense breast screening and help millions of women receive superior care," McCreadie added. "We invest to allow breakthrough innovations to serve patients, and Delphinus is perfectly poised to do exactly that."

    Forchette declined to provide a valuation at which the round was raised, or provide revenue projections. The 10-year-old company had yet to have sales, the CEO said.

    The plan going forward, Forchette said, is to roll out SoftVue in the 50 largest markets around the country. The company is in the process of building out the infrastructure to do so, the CEO said.

    Asked about the potential likelihood for some sort of exit down the road now that Delphinus has reached commercialization stage, Forchette said all options will be on the table going forward, and that includes growing to an independent "multi-billion dollar company," a possible initial public offering or an acquisition by a private equity firm.

    "We're built to allow all of those," he said. "What's really unique about this is it's a breakthrough technology, but it is a breakthrough technology that establishes an entirely new category for a hospital has the potential to create really significant additional revenue as they serve patients, and do it overnight."

    This story first appeared in our sister publication, Crain's Detroit Business.

    Related Articles
    States to give low-income patients access to top-tier cancer providers
    Cancer deaths in Black people drop; still higher than others
    Study mines cancer genetics to help with targeted treatment
    A dirty business: How the medical device sterilization process sickens some to heal others
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    doctor_patient_tablet_getty_i_i.jpg
    How AI may influence pain medication prescriptions
    Amir Dan Rubin
    Amazon's One Medical CEO to step down later this year
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Digital Health Intelligence Newsletter: Sign up to receive a twice-weekly (T, F) morning newsletter featuring the latest reporting on technologies, trends, players and money fueling the rapid changes in how healthcare is developed, paid for and delivered.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing